161 related articles for article (PubMed ID: 30238301)
1. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by
Tang K; Zheng X; Lin J; Zheng M; Lin H; Li T; Wang L
J Nucl Cardiol; 2020 Oct; 27(5):1679-1688. PubMed ID: 30238301
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
Tang K; Lin J; Ji X; Lin T; Sun D; Zheng X; Wang L
J Nucl Cardiol; 2021 Apr; 28(2):610-620. PubMed ID: 31077075
[TBL] [Abstract][Full Text] [Related]
3. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
[TBL] [Abstract][Full Text] [Related]
5. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based
Hu L; Qiu C; Wang X; Xu M; Shao X; Wang Y
BMC Cardiovasc Disord; 2018 Oct; 18(1):203. PubMed ID: 30373519
[TBL] [Abstract][Full Text] [Related]
6. Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.
Moon SH; Hong SP; Cho YS; Noh TS; Choi JY; Kim BT; Lee KH
J Nucl Cardiol; 2017 Jun; 24(3):892-899. PubMed ID: 26510948
[TBL] [Abstract][Full Text] [Related]
7. Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by
Lee HJ; Lee CH; Kim S; Hwang SY; Hong HC; Choi HY; Chung HS; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Metabolism; 2017 Feb; 67():72-79. PubMed ID: 28081780
[TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes.
Lee M; Kim KJ; Chung TH; Bae J; Lee YH; Lee BW; Cha BS; Yun M; Kang ES
Diabetes Obes Metab; 2021 Apr; 23(4):1041-1051. PubMed ID: 33394549
[TBL] [Abstract][Full Text] [Related]
10. Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.
Moon SH; Noh TS; Cho YS; Hong SP; Hyun SH; Choi JY; Kim BT; Lee KH
Angiology; 2015 May; 66(5):472-80. PubMed ID: 24904182
[TBL] [Abstract][Full Text] [Related]
11. Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
Hong SP; Noh TS; Moon SH; Cho YS; Lee EJ; Choi JY; Kim BT; Lee KH
Dig Dis Sci; 2014 Mar; 59(3):607-13. PubMed ID: 24326630
[TBL] [Abstract][Full Text] [Related]
12. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
13. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
[TBL] [Abstract][Full Text] [Related]
14. Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension.
Frille A; Steinhoff KG; Hesse S; Grachtrup S; Wald A; Wirtz H; Sabri O; Seyfarth HJ
Medicine (Baltimore); 2016 Jun; 95(25):e3976. PubMed ID: 27336898
[TBL] [Abstract][Full Text] [Related]
15. The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.
Liu G; Li Y; Hu P; Cheng D; Shi H
Nucl Med Commun; 2015 Jul; 36(7):709-16. PubMed ID: 25757200
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma.
Heckmann MB; Totakhel B; Finke D; Anker MS; Müller-Tidow C; Haberkorn U; Katus HA; Lehmann LH
ESC Heart Fail; 2019 Aug; 6(4):824-829. PubMed ID: 31278857
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
[TBL] [Abstract][Full Text] [Related]
18. The role of (
Pan L; Zhang F; Ran Y; Bi L; Jin H; Yao L
Diagn Interv Radiol; 2023 May; 29(3):548-554. PubMed ID: 37154799
[TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.
Kim G; Jo K; Kim KJ; Lee YH; Han E; Yoon HJ; Wang HJ; Kang ES; Yun M
Cardiovasc Diabetol; 2015 Nov; 14():148. PubMed ID: 26538247
[TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT of the non-malignant liver in an increasingly obese world population.
Keramida G; Peters AM
Clin Physiol Funct Imaging; 2020 Sep; 40(5):304-319. PubMed ID: 32529712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
